Validity of hepatic steatosis indices for prediction of non-alcoholic hepatic steatosis in type 1 diabetic patients

被引：0
|
作者：
Sokolovska, J. [1 ]
Sviklane, L. [1 ]
Olmane, E. [2 ]
Dzerve, Z. [1 ]
Kupcs, K. [2 ]
机构：
[1] Univ Latvia, Lab Personalized Med, Riga, Latvia
[2] Pauls Stradins Univ Hosp, Magnet Resonance Ctr DiaMed, Riga, Latvia
来源：
DIABETOLOGIA | 2017年 / 60卷
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
1244
引用
收藏
页码：S573 / S573
页数：1
相关论文
共 50 条
  • [41] Pathogenesis of hepatic steatosis: The link between hypercortisolism and non-alcoholic fatty liver disease
    Tarantino, Giovanni
    Finelli, Carmine
    WORLD JOURNAL OF GASTROENTEROLOGY, 2013, 19 (40) : 6735 - 6743
  • [42] Hepatic LPI/GPR55 systemregulates the development of non-alcoholic steatosis and steatohepatitis
    Fernandez, Uxia
    Fernandez Fondevila, Marcos
    Gonzalez Rellan, Maria J.
    Da Silva Lima, Natalia
    Buque, Xabier
    Gonzalez, Agueda
    Cardoso Delgado, Teresa
    Varela-Rey, Marta
    Novoa, Eva
    Tojo, Marta
    Dieguez, Carlos
    Marcos, Miguel
    Luz Martinez-Chantar, Maria
    Arrese, Marco
    Garcia-Monzon, Carmelo
    Mato, Jose M.
    Aspichueta, Patricia
    Nogueiras, Ruben
    JOURNAL OF HEPATOLOGY, 2021, 75 : S389 - S391
  • [43] Adipokines and Endotoxemia Correlate with Hepatic Steatosis in Non-Alcoholic Fatty Liver Disease (NAFLD)
    Nier, Anika
    Huber, Yvonne
    Labenz, Christian
    Michel, Maurice
    Bergheim, Ina
    Schattenberg, Joern M.
    NUTRIENTS, 2020, 12 (03)
  • [44] Noninvasive Prediction of Hepatic Steatosis
    Cumberledge, Jeremy
    Angulo, Paul
    AMERICAN JOURNAL OF GASTROENTEROLOGY, 2014, 109 (09): : 1415 - 1416
  • [45] INHIBITION OF ALCOHOLIC HEPATIC STEATOSIS BY A TYPE 1 CANNABINOID RECEPTOR NEUTRAL ANTAGONIST
    Maitra, R.
    Bortoff, K.
    Reggio, P. H.
    Seltzman, H. H.
    ALCOHOLISM-CLINICAL AND EXPERIMENTAL RESEARCH, 2011, 35 (06) : 21A - 21A
  • [46] MASSIVE ALCOHOLIC HEPATIC STEATOSIS AND ACUTE HEPATIC-FAILURE
    MATIASGUIU, X
    PERICAS, MG
    PIQUERAS, AR
    POCH, FJS
    MEDICINA CLINICA, 1987, 89 (13): : 576 - 577
  • [47] Therapeutic effects of granulocyte-colony stimulating factor on non-alcoholic hepatic steatosis in the rat
    Song, Yi-Sun
    Fang, Cheng-Hu
    So, Byung-Im
    Park, Jun-Young
    Jun, Dae Won
    Kim, Kyung-Soo
    ANNALS OF HEPATOLOGY, 2013, 12 (01) : 115 - 122
  • [48] Regulation of fat metabolism in the liver: link to non-alcoholic hepatic steatosis and impact of physical exercise
    J. -M. Lavoie
    M. -S. Gauthier
    Cellular and Molecular Life Sciences CMLS, 2006, 63 : 1393 - 1409
  • [49] Interleukin-17 exacerbates hepatic steatosis and inflammation in non-alcoholic fatty liver disease
    Tang, Y.
    Bian, Z.
    Zhao, L.
    Liu, Y.
    Liang, S.
    Wang, Q.
    Han, X.
    Peng, Y.
    Chen, X.
    Shen, L.
    Qiu, D.
    Li, Z.
    Ma, X.
    CLINICAL AND EXPERIMENTAL IMMUNOLOGY, 2011, 166 (02): : 281 - 290
  • [50] Hepatic fibrosis - and not steatosis - is the main determinant of arterial stiffness in non-alcoholic fatty liver disease
    Yilmaz, Yusuf
    Eren, Fatih
    ATHEROSCLEROSIS, 2019, 290 : 222 - 223
12345